Information till studenter och medarbetare med anledning av covid-19 (Uppdaterad: 27 mars 2020)

På den här webbplatsen använder vi kakor (cookies) för att den ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor. Läs mer om kakor
English
Umeå universitet
printicon
Personalbild Daniel Öhlund

Daniel Öhlund

Bitr. universitetslektor och ST-läkare i onkologi

Wallenberg Molecular Medicine Fellow

Kontakt

E-post
daniel.ohlund@umu.se
Telefon
090-785 17 27, 070-555 40 86

Verksam vid

Anknytning
Biträdande universitetslektor, ST-läkare vid Institutionen för strålningsvetenskaper Enhet: Onkologi
Plats
Klinik: Målpunkt QC11,, Norrlands universitetssjukhus, Forskning: Målpunkt L31, rum 5054. Umeå universitet, Wallenberg Molecular Medicine Fellow, 901 87 Umeå
Anknytning
Anknuten som övrig/annan befattning till Wallenberg centrum för molekylär medicin vid Umeå universitet (WCMM)
Plats
Umeå universitet, 901 87 Umeå
2019
Novel prognostic markers within the CD44-stromal ligand network in pancreatic cancer
Journal of Pathology, John Wiley & Sons 2019, Vol. 5, (2) : 130-141
Franklin, Oskar; Billing, Ola; Öhlund, Daniel; et al.
2019
Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cells
Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences 2019, Vol. 116, (39) : 19609-19618
Tian, Chenxi; Clauser, Karl R.; Öhlund, Daniel; et al.
2019
Stromal biology and therapy in pancreatic cancer: ready for clinical translation?
Gut, BMJ Publishing Group Ltd 2019, Vol. 68, (1) : 159-171
Neesse, Albrecht; Bauer, Christian Alexander; Öhlund, Daniel; et al.
2018
Plasma micro-RNA alterations appear late in pancreatic cancer
Annals of Surgery, Vol. 267, (4) : 775-781
Franklin, Oskar; Jonsson, Pär; Billing, Ola; et al.
2018
VEGF receptor-2/neuropilin 1 trans-complex formation between endothelial and tumor cells is an independent predictor of pancreatic cancer survival
Journal of Pathology, John Wiley & Sons 2018, Vol. 246, (3) : 311-322
Morin, Eric; Sjöberg, Elin; Tjomsland, Vegard; et al.
2017
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Journal of Experimental Medicine, Vol. 214, (3) : 579-596
Öhlund, Daniel
2016
NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer
Cell, Vol. 166, (4) : 936-976
Chio, Iok In Christine; Jafarnejad, Seyed Mehdi; Ponz-Sarvise, Mariano; et al.
2015
Combining conventional and stroma-derived tumour markers in pancreatic ductal adenocarcinoma
Cancer Biomarkers, IOS Press 2015, Vol. 15, (1) : 1-10
Franklin, Oskar; Öhlund, Daniel; Lundin, Christina; et al.
2015
Organoid models of human and mouse ductal pancreatic cancer
Cell, Cell press 2015, Vol. 160, (1-2) : 324-338
Boj, Sylvia F; Hwang, Chang-Il; Baker, Lindsey A; et al.
2014
Fibroblast heterogeneity in the cancer wound
Journal of Experimental Medicine, Vol. 211, (8) : 1503-1523
Öhlund, Daniel; Elyada, Ela; Tuveson, David
2013
Type IV collagen stimulates pancreatic cancer cell proliferation, migration, and inhibits apoptosis through an autocrine loop
BMC Cancer, Vol. 13
Öhlund, Daniel; Franklin, Oskar; Lundberg, Erik; et al.
2009
Type IV collagen is a tumour stroma-derived biomarker for pancreas cancer
British Journal of Cancer, Vol. 101, (1) : 91-97
Öhlund, Daniel; Lundin, Christina; Ardnor, Bjarne; et al.
2008
Expression pattern and circulating levels of endostatin in patients with pancreas cancer
International Journal of Cancer, Vol. 122, (12) : 2805-2810
Öhlund, Daniel; Ardnor, Bjarne; Öman, Mikael; et al.
Visa publikationer i DiVA

Forskargrupper

Forskningsledare
Öhlund Lab

Forskningsprojekt

1 januari 2018
Cancerforskning